|
NYMXF Nymox Pharmaceutical Corp 1018735 |
| Income Statement |
|
Net Income
|
nymox_6k
|
-3,635,000 |
| Balance Sheet |
|
Current Assets
|
623,000 |
|
Assets
|
624,000 |
|
Current Liabilities
|
6,920,000 |
|
Liabilities
|
6,920,000 |
|
Equity
|
-6,296,000 |
|
Shares Out
|
90,515,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-1,884,000 |
| Market Analysis |
Market Cap
|
20,569,474 |
|
Price
|
0.11 |
|
BVPS
|
1.69 |
|
PB
|
0.07 |
|
EPS
|
-0.03 |
|
PS
|
0.38 |
|
FCF
|
-1,884,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NYMXF documents filed with the SEC.
NYMXF Filings
Clear
